Patient Navigation in Cancer Survivorship at a Safety Net Institution
Status
Conditions
Treatments
Details and patient eligibility
About
This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.
Full description
This study seeks to enroll patients receiving a Survivorship Care Plan following curative therapy for cancer. Participants will be randomly assigned to receive usual care or to be followed by a Patient Navigator as part of their Survivorship Care Plan.
Study participation for all participants will be for up to 9 months, with study visits approximately every 3 months, based on standard clinical follow-up. All participants will be administered quality of life surveys by a Clinical Research Associate at study entry, mid-study (approximately 3-6 months) and at study completion.
The following factors will be compared between arms:
- Missed/kept appointments
- Use of urgent/emergent care
- Quality of Life in relation to survivorship care
- Participants lost to care
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Stage I, II, III or IVa Cancer diagnosis (may include Solitary plasmacytoma, Diffuse Large B-Cell Lymphoma (DLBCL), ductal carcinoma in situ (DCIS) of the breast)
- Completed treatment with curative intent within the past 12 months. (May be on maintenance therapy.)
Exclusion criteria
- Distant Metastatic disease
- Non-curable disease
- Recurrence of disease prior to enrollment
- Require ongoing navigation from the treatment navigator
- Enrolled/active in another randomized study (Project SUPPORT)
Trial design
Primary purpose
Allocation
Interventional model
Masking
39 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal